Menu Close

New Eye Drops Offer Hope for Presbyopia Sufferers

PresVu Eye Drops have been approved for presbyopia treatment

India Takes a Leap in Vision Care

A groundbreaking development in ophthalmology has emerged from India. The country’s drug regulatory agency has recently approved a new type of eye drop that could revolutionize the way people with presbyopia, a common age-related vision condition, manage their eyesight.

PresVu: A Game-Changer for Near Vision

Developed by Mumbai-based Entod Pharmaceuticals, PresVu eye drops are designed to reduce the need for reading glasses in individuals suffering from presbyopia. This condition, which affects millions worldwide, causes difficulty in focusing on close objects. As people age, their lenses become less flexible, making it challenging to see clearly up close.

PresVu’s innovative formulation leverages advanced dynamic buffer technology, allowing the drops to adapt to the pH of tears. This ensures consistent efficacy and safety for long-term use, making it a convenient and effective option for those seeking to improve their near vision.

A Non-Invasive Solution

Unlike surgical procedures or laser treatments, PresVu offers a non-invasive approach to addressing presbyopia. Patients can simply apply the drops to their eyes as directed, experiencing improved near vision within 15 minutes.

A Significant Milestone

The approval of PresVu marks a significant milestone in the field of ophthalmology. It provides a much-needed solution for individuals who have grown tired of relying on reading glasses. By offering greater visual independence, PresVu has the potential to enhance the quality of life for millions of people worldwide.

ENTOD Pharmaceuticals received final approval from the Drug Controller General of India.
ENTOD Pharmaceuticals received final approval from the Drug Controller General of India.

Availability and Pricing

PresVu is expected to be available in pharmacies across India starting in the first week of October. The prescription-based eye drops will retail at a price of Rs 350. Initially, the medication will be targeted towards individuals aged 40 to 55 years with mild to moderate presbyopia.

The Future of Vision Care

With the introduction of PresVu, the future of vision care looks promising. As research and development continue to advance, we can anticipate even more innovative solutions that address the challenges of aging eyes.

Source – New eye drops that could eliminate the need for glasses approved in India

Explore more blogs on Health

Posted in Health

Leave a Reply